[1] SANY D,ELSHAHAWY Y,ANWAR W.Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus:variables that influence[J].Saudi J Kidney Dis Transpl,2013,24(2):260-273.
[2] HOSHINO J,HAMANOL T,ABE M,et al.Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients:a cohort study[J].Nephrol Dial Transplant,2018,33(7):1150-1158.
[3] 陈凤锟.糖化白蛋白和糖化血红蛋白评估维持性血液透析的糖尿病患者血糖控制效能的研究[D].北京:中国人民解放军军医进修学院,2010.
[4] ISSHIKI K,NISHIO T,ISONO M,et al.Glycated albumin predicts the risk of mortality in type 2 diabetic patients on hemodialysis:evaluation of a target level for improving survival[J].Ther Apher Dial,2014,18(5):434-442.
[5] LU C,MA W,LIN Y,et al.Glycated albumin predicts long-term survival in patients undergoing hemodialysis[J].Int J Med Sci,2016,13(5):395-402.
[6] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4):292-344.
[7] PEACOCK T P,SHIHABI Z K,BLEYER A J,et al.Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis[J].Kidney Int,2008,73(9):1062-1068.
[8] DIVANI M,GEORGIANOS P I,DIDANGELOS T,et al.Comparison of glycemic markers in chronic hemodialysis using continuous glucose monitoring[J].Am J Nephrol,2018,47(1):21-29.
[9] 周翔海,纪立农,张秀英,等.我国正常糖耐量人群糖化白蛋白的参考范围[J].中国糖尿病杂志,2009,17(8):572-575.
[10] NAKAO T,INABA M,ABE M,et al.Best practice for diabetic patients on hemodialysis 2012[J].Ther Apher Dial,2015,19:40-66.
[11] 陈望,刘尚全,刘心苑.2型糖尿病患者胰岛β细胞功能与血糖波动及不同血糖控制水平的相关性分析[J].现代医学,2018,46(2):204-208.
[12] RIVELINE J P,HADJADJ S.Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes.[J].Diabetes Care,2009,32(12):e155.
[13] KLINGER M,MADZIARSKA K.Mortality predictor pattern in hemodialysis and peritoneal dialysis in diabetic patients[J].Adv Clin Exp Med,2018,28(1):133-135.
[14] PAPADEMETRIOU V,LOVATOL L,DOUMAS M,et al.Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes[J].Kidney Int,2015,87(3):649-659. |